Cargando…
Microbial Delivery Vehicles for Allergens and Allergen-Derived Peptides in Immunotherapy of Allergic Diseases
Allergen-specific immunotherapy represents the only available curative approach to allergic diseases. The treatment has proven effective, but it requires repetitive administrations of allergen extracts over 3–5 years and is often associated with adverse events. This implies the need for novel therap...
Autores principales: | Zahirović, Abida, Lunder, Mojca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6036130/ https://www.ncbi.nlm.nih.gov/pubmed/30013543 http://dx.doi.org/10.3389/fmicb.2018.01449 |
Ejemplares similares
-
Allergen Peptides, Recombinant Allergens and Hypoallergens for Allergen-Specific Immunotherapy
por: Marth, Katharina, et al.
Publicado: (2014) -
Allergen‐specific immunotherapy by recombinant Der P1 allergen‐derived peptide‐based vaccine in an allergic mouse model
por: Asoudeh Moghanloo, Soheila, et al.
Publicado: (2023) -
Immunotherapy with Allergen Peptides
por: Larché, Mark
Publicado: (2007) -
Mechanisms of Allergen Immunotherapy in Allergic Rhinitis
por: Drazdauskaitė, Gabija, et al.
Publicado: (2020) -
Allergic asthma: An indication for allergen immunotherapy
por: Ankermann, Tobias, et al.
Publicado: (2023)